AU Patent

AU2014333979B2 — Novel derivative of an insulin analogue

Assigned to Novo Nordisk AS · Expires 2018-02-15 · 8y expired

What this patent protects

The present invention provides a novel derivative of an analogue of human insulin, useful for the treatment of diabetes.

USPTO Abstract

The present invention provides a novel derivative of an analogue of human insulin, useful for the treatment of diabetes.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014333979B2
Jurisdiction
AU
Classification
—
Expires
2018-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.